LIC MF Healthcare Fund Regular Growth
- Sector - Healthcare
- Equity
- Very High Risk
Rating:
Key Metrics
Aum
₹88.96 Cr
Expense Ratio
2.10%
Exit Load
1.00%
Min. Investment
₹5,000.00
Min. SIP
₹200.00
Launch Date
28 Feb 2019
CAGR Returns
| Period | Absolute(%) | Annualised(%) |
|---|---|---|
| 1 Month | +7.69% | -- |
| 3 Months | +16.4% | -- |
| 6 Months | +14.36% | -- |
| 1 Year | +9.56% | +9.56% |
| 2 Years | -- | +12.42% |
| 3 Years | +81.12% | +21.9% |
| 5 Years | +67.63% | +10.88% |
| Since Launch | +228.55% | +17.49% |
Holdings as on 18 Jul 2026
| Name | Value (₹Cr) | Holding % |
|---|---|---|
| Sun Pharmaceutical Industries | 9.77 | 10.55 |
| Divi's Laboratories | 6.64 | 7.17 |
| Apollo Hospitals Enterprise | 6.27 | 6.77 |
| Torrent Pharmaceuticals | 6.07 | 6.55 |
| Neuland Laboratories | 5.32 | 5.74 |
| Navin Fluorine International | 5.17 | 5.58 |
| Aurobindo Pharma | 4.91 | 5.30 |
| Treps | 4.85 | 5.24 |
| Zydus Lifesciences | 4.73 | 5.11 |
| Fortis Healthcare | 4.12 | 4.45 |
Morning Star Rating
Rating:
Risk
Return
Risk & Volitility
0.90
Sharpe Ratio
16.05%
Std. Deviation
--
Tracking Error
--
Alpha
--
Beta
Peer Comparison
| Fund Name | 1Y | 3Y | 5Y |
|---|---|---|---|
| LIC MF Healthcare Fund Regular Growth | +9.56% | +21.9% | +10.88% |
| ITI Pharma and Healthcare Fund Regular Growth | +5.12% | +19.17% | -- |
| WhiteOak Capital Pharma and Healthcare Fund Regular Growth | +16.85% | -- | -- |
| Quant Healthcare Fund Regular Growth | +10.77% | -- | -- |
| PGIM India Healthcare Fund Regular Growth | +14.92% | -- | -- |
Results are calculated on CAGR basis
About Fund
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.
The LIC MF Healthcare Fund Regular Growth has an AUM of 88.96 crores & has delivered CAGR of 10.88 in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 2.10%. The minimum investment in LIC MF Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 200.
As per morningstar the risk & return rating of the fund are Medium & High respectively.
The fund has a present cash holding of %. The top holdings of the fund include Sun Pharmaceutical Industries, Divi's Laboratories, Apollo Hospitals Enterprise, Torrent Pharmaceuticals.
The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs, Chemical Manufacturing.
Some of the similar funds are LIC MF Healthcare Fund Regular Growth, ITI Pharma and Healthcare Fund Regular Growth, WhiteOak Capital Pharma and Healthcare Fund Regular Growth, Quant Healthcare Fund Regular Growth, PGIM India Healthcare Fund Regular Growth. LIC MF Healthcare Fund Regular Growth has a sharpe ratio of 0.90 & a standard deviation of 16.05%.
FAQs
According to the morning star rating LIC MF Healthcare Fund Regular Growth has a Medium risk & High return.
LIC MF Healthcare Fund Regular Growth is managed by Sudhanshu Asthana.
The expense ratio of LIC MF Healthcare Fund Regular Growth is 2.10%.
The 5 year annualized return on LIC MF Healthcare Fund Regular Growth is 10.88% & it has generated 9.56% in the last 1 year.
The minimum investment in LIC MF Healthcare Fund Regular Growth is 5000 Rs.
LIC MF Healthcare Fund Regular Growth has an AUM of 88.96 crores.
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.